Please use this identifier to cite or link to this item:
Title: SH3BP2 Silencing Increases miRNAs Targeting ETV1 and Microphthalmia-Associated Transcription Factor, Decreasing the Proliferation of Gastrointestinal Stromal Tumors
Author: Proaño Pérez, Elisabeth
Serrano Candelas, Eva
Mancia, Cindy
Navinés Ferrer, Arnau
Guerrero, Mario
Martín Andorrà, Margarita
Keywords: Cicle cel·lular
Càncer gastrointestinal
Micro RNAs
Factors de transcripció
Cell cycle
Gastrointestinal cancer
Transcription factors
Issue Date: 15-Dec-2022
Publisher: MDPI
Abstract: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. Gain of function in receptor tyrosine kinases type III, KIT, or PDGFRA drives the majority of GIST. Previously, our group reported that silencing of the adaptor molecule SH3 Binding Protein 2 (SH3BP2) downregulated KIT and PDGFRA and microphthalmia-associated transcription factor (MITF) levels and reduced tumor growth. This study shows that SH3BP2 silencing also decreases levels of ETV1, a required factor for GIST growth. To dissect the SH3BP2 pathway in GIST cells, we performed a miRNA array in SH3BP2-silenced GIST cell lines. Among the most up-regulated miRNAs, we found miR-1246 and miR-5100 to be predicted to target MITF and ETV1. Overexpression of these miRNAs led to a decrease in MITF and ETV1 levels. In this context, cell viability and cell cycle progression were affected, and a reduction in BCL2 and CDK2 was observed. Interestingly, overexpression of MITF enhanced cell proliferation and significantly rescued the viability of miRNA-transduced cells. Altogether, the KIT-SH3BP2-MITF/ETV1 pathway deserves to be considered in GIST cell survival and proliferation.
Note: Reproducció del document publicat a:
It is part of: Cancers, 2022, vol. 14, num. 24, p. 6198
Related resource:
ISSN: 2072-6694
Appears in Collections:Articles publicats en revistes (Biomedicina)

Files in This Item:
File Description SizeFormat 
727909.pdf2.88 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons